Clinical Trials Browser

Unknown × Multiple Myeloma × CT103A chimeric antigen receptor × Clear all

NCT05698303 2023-01-26

A Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A) in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

Phase 1 Unknown

Multiple Myeloma

NCT05066646 2021-11-23

FUMANBA-1

Phase 1/2 Unknown

Multiple Myeloma